Sleep Research
Sleep is characterized by altered consciousness, it is split into two distinct stages- rapid eye movement (REM) and non-REM. The circadian clock controls the pattern of sleep and wakefulness. It is regulated by the light levels, temperature, metabolites, neurotransmitters, neuropeptides, and neurohormones, which cause a daily fluctuation in expression levels of many sleep-related genes.
Sleep Research Products Targets
- Adenosine A2A Receptor (11)
- GABAB Receptor (28)
- 5-HT2C Receptor (23)
- 5-HT2B Receptor (12)
- 5-HT2A Receptor (25)
- Melatonin Receptor (10)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- Retinoic Acid-related Orphan Receptor (4)
- Rev-Erb Receptor (2)
- DREADD Ligands (1)
- D3 Receptor (12)
- 5-HT3 Receptor (39)
- D2 Receptor (14)
- Histamine H3 Receptor (22)
- Adenosine A1 Receptor (12)
- OX2 Receptor (4)
- OX1 Receptor (5)
Products for Sleep Research - Page 18
- Cat.No. Product Name Information/Activity
-
BCC5680
m-CPP hydrochloride
13078-15-4
-
BCC6696
α-Methyl-5-hydroxytryptamine maleate
97469-12-0
-
BCC7657
ATC 0175 hydrochloride
MCH<sub>1</sub> antagonist; also 5-HT<sub>2B</sub> antagonist and 5-HT<sub>1A</sub> partial agonist
-
BCC7856
LY 266097 hydrochloride
172895-39-5
-
BCC7558
LY 272015 hydrochloride
172895-15-7
-
BCC5751
SB 200646 hydrochloride
143797-62-0
-
BCC7035
SB 204741
152239-46-8
-
BCC7143
SB 206553 hydrochloride
1197334-04-5
-
BCC7040
SB 221284
196965-14-7
-
BCC7036
SB 228357
SB228357 is a selective, potent oral active 5-HT2C/2B receptor antagonist with pKi values of 6.9, 8.0 and 9.0 for 5-HT2A, 5-HT2B and 5-HT2C, respectively. SB228357 has antidepressant/anxiolytic effects.
